依托泊苷为细胞周期特异性抗肿瘤药物,作用于DNA拓扑异构酶Ⅱ,形成药物-酶- DNA稳定的可逆性复合物,阻碍DNA修复。实验发现这复合物可随药物的清除而逆转 ,使损伤的DNA得到修复,降低了细胞毒作用。因此,延长药物的给药时间,可能 提高抗肿瘤活性。
该产品通过国内GMP认证、美国FDA认证,并获得欧洲CEP证书。
依托泊苷CAS号:33419-42-0
依托泊苷分子式: C29H32O13
依托泊苷英文名称: Etoposide
依托泊苷英文同义词: TENIPOSIDE; 4'-demethylepipodophyllotoxin-(4,6-o-(r)-ethylidene-beta-d-glucopyranoside); 4-demethylepipodophyllotoxin-beta-d-ethylideneglucoside; (8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside; (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-mannopyranoside; (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1S)-ethylidene]-beta-D-mannopyranoside; (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-alpha-L-gulopyranoside; (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1S)-ethylidene]-alpha-L-gulopyranoside
依托泊苷EINECS号: 251-509-1
依托泊苷分子量: 588.5566
依托泊苷熔点: 236-251℃
依托泊苷沸点: 798.054°C at 760 mmHg
依托泊苷密度: 0mmHg at 25°C
依托泊苷闪点: 263.603°C